<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Nutrition</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Nutr.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnut.2026.1797644</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Ketogenic metabolic therapies in prevention &#x00026; treatment of non-communicable diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Cavan</surname> <given-names>David</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<uri xlink:href="https://loop.frontiersin.org/people/2747873"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kovarik</surname> <given-names>Johannes J.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<uri xlink:href="https://loop.frontiersin.org/people/1191676"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Voshol</surname> <given-names>Peter J.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<uri xlink:href="https://loop.frontiersin.org/people/37514"/>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>University Hospitals Dorset NHS Foundation Trust</institution>, <city>Bournemouth</city>, <country country="gb">United Kingdom</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Internal Medicine III Clinical Division of Nephrology and Dialysis, Medical University of Vienna</institution>, <city>Vienna</city>, <country country="at">Austria</country></aff>
<aff id="aff3"><label>3</label><institution>Independent Researcher</institution>, <city>Culemborg</city>, <country>Netherlands</country></aff>
<author-notes>
<corresp id="c001"><label>&#x0002A;</label>Correspondence: Peter J. Voshol, <email xlink:href="mailto:p.j.voshol@gmail.com">p.j.voshol@gmail.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-17">
<day>17</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>13</volume>
<elocation-id>1797644</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2026 Cavan, Kovarik and Voshol.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Cavan, Kovarik and Voshol</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-17">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>cellular energy homeostasis</kwd>
<kwd>deprescription</kwd>
<kwd>epigenetic modulation</kwd>
<kwd>Ketogenic Metabolic Therapy</kwd>
<kwd>metabolic flexibility</kwd>
<kwd>neuro-inflammation</kwd>
<kwd>nutritional ketosis</kwd>
<kwd>transdiagnostic remission</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="3"/>
<word-count count="1472"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nutrition and Metabolism</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes notes-type="frontiers-research-topic">
<p><bold>Editorial on the Research Topic</bold> <ext-link xlink:href="https://www.frontiersin.org/research-topics/64643/ketogenic-metabolic-therapies-in-prevention-x-treatment-of-non-communicable-diseases" ext-link-type="uri">Ketogenic metabolic therapies in prevention &#x00026; treatment of non-communicable diseases</ext-link></p></notes>
</front>
<body>
<sec id="s1">
<title>A wondering mind on the metabolic shift</title>
<p>Many of the chronic diseases that have traditionally been regarded as unavoidable features of aging may instead reflect maladaptive physiological responses arising from a mismatch between contemporary environmental exposures, nutrition and evolutionarily conserved metabolic regulatory systems. In considering the 19 articles included in this Research Topic, one is left with a sense of scientific curiosity and re-evaluation of prevailing models. Collectively, these works illustrate a transition away from a glucose-dominant framework toward one that seeks to restore the organism&#x00027;s inherent metabolic flexibility, characterized by the capacity to alternate efficiently between carbohydrate- and lipid-derived fuels.</p>
<p>For a long time, we viewed the ketogenic diet as a niche tool for epilepsy. However, the evidence presented here suggests that Ketogenic Metabolic Therapy (KMT) is a systemic intervention that re-tunes the body&#x00027;s fundamental signaling pathways. We find ourselves asking: how deep does this metabolic rabbit hole go?</p></sec>
<sec id="s2">
<title>The gut as the metabolic gateway</title>
<p>Perhaps the most provocative question raised in this volume concerns the gut. In our traditional view, a healthy gut requires high fiber and diverse plant intake. Yet, the case series by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2024.1467475">Norwitz and Soto-Mota</ext-link> regarding a carnivore-ketogenic diet for Inflammatory Bowel Disease (IBD) invites us to pause. How is it that patients with severe Crohn&#x00027;s disease and ulcerative colitis&#x02014;conditions defined by intractable inflammation&#x02014;can achieve remission by removing plant-based irritants and shifting to a fat-and-protein-based metabolism?</p>
<p>This gut-health link is likely not just about what is being removed, but what is being produced. We wonder if the production of &#x003B2;-hydroxybutyrate (&#x003B2;HB) serves as a restorative signal for the intestinal barrier. By suppressing the NLRP3 inflammasome, KMT might be providing the gut with the &#x0201C;metabolic silence&#x0201D; it needs to repair itself. This theme is echoed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1591937">Newiss</ext-link>, who utilized a carnivore-ketogenic approach to achieve remission in schizophrenia, suggesting that for some individuals, gut-derived inflammation may be the primary driver of neuro-inflammation. The gut, it seems, is not just where we absorb nutrients, but the primary site where our metabolic and immune systems negotiate peace.</p></sec>
<sec id="s3">
<title>The metabolic mind and the end of silos</title>
<p>The psychiatric evidence in this volume is nothing short of transformative. We see remission in schizoaffective disorder (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1506304">Laurent, Bellamy, Tague et al.</ext-link>), major depressive disorder (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1549782">Laurent, Bellamy, Hristova et al.</ext-link>), obsessive-compulsive disorder (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1568076">MacDonald and Palmer</ext-link>), and bipolar disorder (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1635489">Schreel et al.</ext-link>). We are left to wonder: have we been misclassifying metabolic brain disorders as purely &#x0201C;psychiatric&#x0201D; for too long?</p>
<p>When a patient experiences &#x0201C;transdiagnostic remission&#x0201D; of PTSD, ADHD, and binge-eating disorder simultaneously through KMT (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1600123">Bellamy and Laurent</ext-link>), it suggests that these are not separate silos of disease, but different branches of the same metabolic tree. This is further supported by the bibliometric analysis of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1479699">Yan et al.</ext-link>, which highlights the explosive growth in research linking the ketogenic diet to brain health. Whether through improving mitochondrial function or modulating neurotransmitters, KMT appears to offer the brain a more stable and efficient fuel source.</p></sec>
<sec id="s4">
<title>Expanding the horizon: kidneys and bones</title>
<p>The reach of KMT extends into territories we once thought were purely &#x0201C;structural&#x0201D; or &#x0201C;genetic.&#x0201D; The study on Autosomal Dominant Polycystic Kidney Disease (ADPKD) by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1624639">Muensterman et al.</ext-link> shows that nutritional ketosis can actually improve renal function and quality of life in this peculiar population of patients with chronic kidney disease (CKD). Similarly, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1609737">Athinarayanan et al.</ext-link> demonstrate that a remote-care ketogenic intervention can stabilize and even may improve kidney function markers and reduce systemic inflammation in Type 2 Diabetes (T2D) and CKD.</p>
<p>Even our skeletal and reproductive systems appear to be metabolically sensitive. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1508695">Luo et al.</ext-link> review how &#x003B2;HB influences bone remodeling, suggesting a potential role for KMT in treating osteoporosis.</p></sec>
<sec id="s5">
<title>Mechanism and the nuances of sex and fertility</title>
<p>As physiologists, we are fascinated by the &#x0201C;under the hood&#x0201D; mechanics revealed in this volume. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2024.1467719">Eldakhakhny et al.</ext-link> provide evidence that a low-carbohydrate, high-fat diet can modulate autophagy and endoplasmic reticulum (ER) stress, protecting the heart and blood vessels from the damage of metabolic syndrome.</p>
<p>However, we must remain curious about the differences in how we respond. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1554743">Moss et al.</ext-link> highlight sex-specific metabolic responses, showing that males and females may experience different histone modifications and metabolic shifts in response to KMT. This reminds us that &#x0201C;one size fits all&#x0201D; has no place in the future of metabolic medicine. We must also consider how we monitor these shifts; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1629921">Fante et al.</ext-link> argue for the importance of rigorous &#x003B2;HB testing to ensure that patients are within the therapeutic windows necessary for these profound physiological changes.</p>
<p>Meanwhile, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2024.1529466">May et al.</ext-link> explore how fasting and metabolic shifts might influence male fertility, reminding us that every cell in the body is a metabolic actor.</p></sec>
<sec id="s6">
<title>A condensed conclusion and future perspective</title>
<p>The collective weight of these 19 papers suggests that we are at the dawn of a new era. KMT is no longer just a &#x0201C;weight loss diet&#x0201D;; it is a sophisticated metabolic intervention that can reverse disease processes once thought to be permanent. From the resolution of IBD to the stabilization of psychiatric crises and the protection of renal function, the common denominator is a restoration of cellular energy homeostasis.</p>
<p>The TOWARD study (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1548609">Buchanan et al.</ext-link>) reminds us of the practical implications: significant weight loss, the deprescription of dozens of medications, and substantial healthcare cost savings. This is a rare &#x0201C;win-win&#x0201D; in medicine.</p></sec>
<sec id="s7">
<title>Future directions</title>
<p>Looking ahead, we must continue to ask the &#x0201C;uncomfortable&#x0201D; questions with an open mind. We need:
<list list-type="bullet">
<list-item><p>More research into the carnivore-gut interface to understand why the elimination of plant-based foods facilitates such deep healing in some IBD and psychiatric patients.</p></list-item>
<list-item><p>Precision KMT protocols that account for the sex-specific epigenetic changes and individual pharmacokinetic profiles (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2024.1470331">Nishioka et al.</ext-link>).</p></list-item>
<list-item><p>Long-term feasibility studies in diverse populations, such as the Parkinson&#x00027;s study by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnut.2025.1601446">Worster et al.</ext-link>, to ensure these interventions are sustainable.</p></list-item>
</list></p>
<p>We invite the scientific community to move forward not with fixed answers, but with the same curiosity that has driven this volume. The metabolic revolution is here, and it is teaching us that the body has a remarkable, untapped capacity for healing when we finally provide it with the right metabolic signals.</p></sec>
</body>
<back>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>PV: Writing &#x02013; original draft. JK: Writing &#x02013; review &#x00026; editing. DC: Writing &#x02013; review &#x00026; editing.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s9">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Edited and reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/970906/overview">Barbara R. Cardoso</ext-link>, Monash University, Australia</p>
</fn>
</fn-group>
</back>
</article>